Pharmaceutical quality

  Improving compliance in Indian Pharma industry -       Ganadhish Kamat USFDA scores each site inspected by them based on the inspection outcome. The site inspection score provides one measure of a site’s compliance to CGMP regulations. Report on the State of Pharmaceutical Quality for 2019 published by CDER, included a summary of site inspection scores by different regions of the world. This summary showed that the average inspection score across the globe was 7.4. While the average scores of the sites in EU (7.7) and US (7.6) were above the global average, the average site scores in China (7.1), ROW (7.0) and India (6.8) were less, with Indian average being the least.   Indian sites also had large share of warning letters issued globally in last few years. The analysis of the warning letters issued to Indian sites since 2015 is given below – After going through individual warning letters it is clear that the concerns raised in the warning letters were largely related t

                                   -       Ganadhish Kamat     As per the Drugs and Cosmetics act 1940, Central Drugs Standard Control Organization (CDSCO) is the highest drug regulatory body of India headed by Drugs Controller General of India. The Vision of CDSCO is “To protect and promote public health in India” whereas the mission is defined as “To safeguard and enhance the public health by assuring the safety, efficacy and Quality of the drugs, cosmetics and medical devices. The strategies have been listed as follows – 1.        Initiate in framing of rules, regulations and guidance documents to match the contemporary issues in compliance with the requirements of Drugs & Cosmetics Act 1940 and Rules 1945. 2.        Facilitate in uniform implementation of the provisions of the Drugs & Cosmetics Act 1940 and Rules 1945. 3.        Function as Central license Approving Authority under the provisions of Drugs and Cosmetics Act 1940 and Rules 1945. 4.        Collab